Search results
Pancreatic cancer: Some signs that cancer has spread
Medical News Today· 4 days agoWhen pancreatic cancer spreads to other areas of the body, a person may experience new symptoms that are not directly linked to the tumors in the...
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 2 days agoVerastem Oncology reported positive initial results from an ongoing Phase I/II trial investigating...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 2 days agoFN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention ...
Liposomal Irinotecan for Pancreatic Cancer: Is It Worth It?
Medscape· 5 days agoIn February, the US Food and Drug Administration approved irinotecan liposome (Onivyde) as part of a...
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
Zacks via Yahoo Finance· 2 days agoVerastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line...
For most, pancreatic cancer is a deadly diagnosis. How one Fort Worth man beat the odds
Fort Worth Star-Telegram McClatchy via AOL· 6 days ago“Where we are now for pancreatic cancer is where we were for colon cancer maybe 40 years ago,”...
BioLineRx reports positive pancreatic cancer trial results By Investing.com
Investing.com· 2 days agoBioLineRx Ltd. (NASDAQ: BLRX), a biopharmaceutical company, announced encouraging results from the...
TV’s ‘nicest judge’ announced he had cancer. This Miami hospital just gave an update
Miami Herald via Yahoo News· 1 day agoThe “Caught in Providence” star, who often went viral for the compassion he showed defendants in his...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga via AOL· 2 days ago:VSTM) announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2...
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...
FOX 23 News Albany· 2 days agoOne is a trial-in-progress abstract discussing cohort 5 of the GOBLET study, which will evaluate the combination of pelareorep and modified FOLFIRINOX (mFOLFIRINOX) with and without atezolizumab ...